Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Aveo Pharma Amends Agreement With Biodesix For Ficlatuzumab 12
Aveo To Enter Into Co-Development Agreement For Lung Cancer Drug 14
National Comprehensive Cancer Enters Into Co-Development Agreement With AVEO Pharma And Astellas Pharma 15
Licensing Agreements 17
CANbridge Life Sciences Enters into Licensing Agreement with AVEO Oncology 17
EUSA Pharma Exercises Option for Licensing Agreement with AVEO Pharma for TiNivo Combination Study 19
Novartis to Terminate Licensing Agreement with Aveo Pharma 21
AVEO Pharma Amends Licensing Agreement with St. Vincent’s 22
Equity Offering 23
AVEO Pharma Prices Public Offering of Shares for USD5.7 Million 23
AVEO Pharma Raises USD6 Million in Public Offering of Shares upon Exercise of Warrants 25
AVEO Pharma Raises USD17.2 Million in Public Offering of Shares 26
Aveo Pharma Raises USD10.2 Million in Public Offering of Common Stock 27
Aveo Pharma Raises USD17 Million in Private Placement of Units 28
Aveo Pharma Completes Public Offering Of Shares For US$57.5 Million 30
AVEO Pharmaceuticals Inc – Key Competitors 31
AVEO Pharmaceuticals Inc – Key Employees 32
AVEO Pharmaceuticals Inc – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Financial Announcements 34
Aug 07, 2018: Aveo reports second quarter 2018 financial results and provides business update 34
May 08, 2018: AVEO Reports First Quarter 2018 Financial Results and Provides Business Update 36
Mar 13, 2018: AVEO Reports Full Year 2017 Financial Results and Provides Business Update 39
Nov 07, 2017: AVEO Reports Third Quarter 2017 Financial Results and Provides Business Update 42
Aug 09, 2017: AVEO Reports Second Quarter 2017 Financial Results and Provides Business Update 44
May 04, 2017: AVEO Reports First Quarter 2017 Financial Results and Provides Business Update 46
Mar 22, 2017: AVEO Reports Full Year 2016 Financial Results and Provides Business Update 48
Corporate Communications 50
Jun 15, 2018: AVEO Oncology added to the Russell 2000, Russell 3000, and Russell Microcap indexes 50
Nov 20, 2017: AVEO Announces Appointment of Nikhil Mehta, Ph.D., as Senior Vice President of Regulatory and Quality Assurance 51
May 16, 2017: AVEO Oncology appoints new CFO 52
Product News 53
09/13/2017: AVEO Oncology Announces Receipt of $0.5 million Payment from CANbridge 53
04/03/2017: AVEO Announces Milestone Payment from CANbridge for AV-203 54
Product Approvals 55
Aug 20, 2018: Development partner Boehringer Ingelheim supplies clinical material manufactured in China for new cancer drug 55
Aug 14, 2018: AVEO announces acceptance of CANbridge Investigational New Drug Application for CAN017 (AV-203) trial in esophageal squamous cell cancer (ESCC) in China 56
Dec 21, 2017: CANbridge Life Sciences Submits Investigational New Drug Application for CAN017 Trial in Esophageal Squamous Cell Cancer (ESCC) In China 57
Clinical Trials 58
Dec 07, 2017: AVEO Oncology Announces Clinical Update on Ficlatuzumab 58
Jun 05, 2017: AVEO Oncology and Biodesix Announce Results from Two Investigator-Sponsored Phase 1 Studies of HGF Targeted Antibody Ficlatuzumab at the 2017 ASCO Annual Meeting 59
Apr 20, 2017: AVEO To Provide Update on Pipeline Drug Ficlatuzumab at 2017 ASCO Annual Meeting 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
AVEO Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aveo Pharma Amends Agreement With Biodesix For Ficlatuzumab 12
Aveo To Enter Into Co-Development Agreement For Lung Cancer Drug 14
National Comprehensive Cancer Enters Into Co-Development Agreement With AVEO Pharma And Astellas Pharma 15
CANbridge Life Sciences Enters into Licensing Agreement with AVEO Oncology 17
EUSA Pharma Exercises Option for Licensing Agreement with AVEO Pharma for TiNivo Combination Study 19
Novartis to Terminate Licensing Agreement with Aveo Pharma 21
AVEO Pharma Amends Licensing Agreement with St. Vincent’s 22
AVEO Pharma Prices Public Offering of Shares for USD5.7 Million 23
AVEO Pharma Raises USD6 Million in Public Offering of Shares upon Exercise of Warrants 25
AVEO Pharma Raises USD17.2 Million in Public Offering of Shares 26
Aveo Pharma Raises USD10.2 Million in Public Offering of Common Stock 27
Aveo Pharma Raises USD17 Million in Private Placement of Units 28
Aveo Pharma Completes Public Offering Of Shares For US$57.5 Million 30
AVEO Pharmaceuticals Inc, Key Competitors 31
AVEO Pharmaceuticals Inc, Key Employees 32
AVEO Pharmaceuticals Inc, Subsidiaries 33
List of Figures
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9